A4	Androstenedione
AMH	Anti-Mullerian hormone
ANP	Atrial natriuretic peptice
APN	Adiponectin
AUC	Area under the curve
Anov	Anovulatory
BMI	Body mass index
bpm	Beats per minute
CAT	Continuous aerobic training
cd	Cycle days
CG	Control group
d	Days
DHEA-S	Dehydroepiandrosterone sulfate
E1-S	Estrone sulfate
E2	Estradiol
Ex	Exercise
ExEE	Exercise energy expenditure
FAI	Free androgen index
FBG	Fasting blood glucose
FFM	Fat free mass
FI	Fasting insulin
FSH	Follicle stimulating hormone
fT	Free testosterone
GDR	Glucose disposal rate
GIR	Glucose infusion rate
HIIT	High intensity interval training
HMW	High molecular weight
HOMA-IR	Homeostatic model assessment of insulin resistance
HR	Heart rate
HRM	Heart rate monitor
HRR	Heart rate reserve
IAT	Intermittent aerobic training
II	Intensity interval
Ins	Insulin
IR	Insulin resistance
IS	Insulin sensitivity
LH	Luteinizing hormone
Met	Metformin
MICT	Medium intensity continuous training
Mo	Month (s)
N/A	Not applicable
NW	Normoweight
OB	Overweight or obese
OC	Oral contraceptive
OGTT	Oral glucose tolerance test
Ov	Ovulatory
PA	Physical activity
PRL	Prolactin
PRT	Progressive resistance training
RCT	Randomized controlled trial
Reps	Repetitions
RM	Repetition maximum
SHBG	Sex hormone binding globulin
ST	Strength training
T	Testosterone
T4	Thyroxine
TSH	Thyroid stimulating hormone
TT	Total testosterone
Wk	Week (s)
Wt	Weight
Y	Year (s)